Question follow-through · 96652

Contracts: China

To ask the Minister for the Cabinet Office, whether any Chinese companies are under investigation under the Procurement Act 2023.

answeredCabinet Office

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Cabinet Office
Tabled
3 Dec 2025
Target answer date
8 Dec 2025
Answer
9 Dec 2025 · 6 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

Recorded timeline

  1. 3 Dec 2025

    Question tabled

    To ask the Minister for the Cabinet Office, whether any Chinese companies are under investigation under the Procurement Act 2023.

  2. 8 Dec 2025

    Target answer date

    Date supplied by the official written-questions record.

  3. 9 Dec 2025

    Answer published

    The Procurement Act 2023 allows the Government to investigate and, where appropriate, add suppliers to a centrally managed debarment list. Addition to the list impacts on a supplier’s eligibility for public contracts. These decisions can be taken on multi...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

National Security: Procurement

5 Dec 2025 · To ask the Minister for the Cabinet Office, what criteria does the Government use to determine whether a company constitutes a threat to national security and is thus placed under investigation by the Procurement Act 2023.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Genomics: Information Sharing

5 Dec 2025 · To ask the Minister for the Cabinet Office, what formal guidance, policies, or risk assessments has the UK government issued to UK research institutions, NHS bodies, and private genomics companies regarding the sharing of genomic data with foreign entitie